{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:37:47Z","timestamp":1791074267804,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.amjcard.2012.02.026","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T06:34:13Z","timestamp":1332916453000},"page":"1801-1806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Usefulness of Intravenous Adenosine in Idiopathic Pulmonary Arterial Hypertension as a Screening Agent for Identifying Long-Term Responders to Calcium Channel Blockers"],"prefix":"10.1016","volume":"109","author":[{"given":"Xiang-Rong","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Cheng","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2012.02.026_bib1","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0735-1097(91)90556-O","article-title":"High dose titration of calcium channel blocking agents for primary pulmonary hypertension: guidelines for short-term drug testing","volume":"18","author":"Rich","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.02.026_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2012.02.026_bib3","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0735-1097(98)00361-1","article-title":"Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine","volume":"32","author":"Ricciardi","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.02.026_bib4","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.02.026_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2012.02.026_bib6","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/0735-1097(92)90295-X","article-title":"Comparison of the effects of adenosine and nifedipine in pulmonary hypertension","volume":"19","author":"Schrader","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.02.026_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1183\/09031936.98.12020265","article-title":"Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension","volume":"12","author":"Sitbon","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjcard.2012.02.026_bib8","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","article-title":"ACCF\/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association","volume":"119","author":"McLaughlin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.02.026_bib9","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2012.02.026_bib10","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/01.CIR.84.3.1145","article-title":"Adenosine as a vasodilator in primary pulmonary hypertension","volume":"84","author":"Morgan","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.02.026_bib11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1378\/chest.107.1.54","article-title":"Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension","volume":"107","author":"Nootens","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2012.02.026_bib12","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1183\/09031936.00033809","article-title":"Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer?","volume":"33","author":"Opitz","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjcard.2012.02.026_bib13","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1183\/09031936.00169608","article-title":"Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension","volume":"33","author":"Jing","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjcard.2012.02.026_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0306-3623(98)00184-0","article-title":"Effect of adenosine on pulmonary circulation of rabbits","volume":"32","author":"El-Kashef","year":"1999","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.amjcard.2012.02.026_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0008-6363(99)00059-0","article-title":"Adenosine plasma concentration in pulmonary hypertension","volume":"43","author":"Saadjian","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.amjcard.2012.02.026_bib16","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0002-9149(99)00881-4","article-title":"Plasma beta-endorphin and adenosine concentration in pulmonary hypertension","volume":"85","author":"Saadjian","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2012.02.026_bib17","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/eurheartj\/ehq170","article-title":"Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension","volume":"31","author":"Montani","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2012.02.026_bib18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.rmed.2009.11.015","article-title":"Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension","volume":"104","author":"Tonelli","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.amjcard.2012.02.026_bib19","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.CIR.86.3.896","article-title":"Adenosine infusion for the reversal of pulmonary vasoconstriction in biventricular failure","volume":"86","author":"Haywood","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.02.026_bib20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.rmed.2009.11.010","article-title":"Adenosine for vasoreactivity testing in pulmonary hypertension: a head-to-head comparison with inhaled nitric oxide","volume":"104","author":"Oliveira","year":"2010","journal-title":"Respir Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912007035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912007035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:02:29Z","timestamp":1762077749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914912007035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0002914912007035"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2012.02.026","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of Intravenous Adenosine in Idiopathic Pulmonary Arterial Hypertension as a Screening Agent for Identifying Long-Term Responders to Calcium Channel Blockers","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2012.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}